151 related articles for article (PubMed ID: 18677072)
1. Factors associated with zidovudine receipt and prenatal care among HIV-infected pregnant women in New Jersey.
Abatemarco DJ; Catov JM; Cross H; Delnevo C; Hausman A
J Health Care Poor Underserved; 2008 Aug; 19(3):814-28. PubMed ID: 18677072
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
3. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
4. Vertical HIV-1 transmission: prophylaxis and paediatric follow-up.
Carneiro M; Sanchéz A; Maneiro P; Angelosante W; Pérez C; Valleé M
Placenta; 2001 Apr; 22 Suppl A():S13-8. PubMed ID: 11312622
[TBL] [Abstract][Full Text] [Related]
5. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
Thaineua V; Sirinirund P; Tanbanjong A; Lallemant M; Soucat A; Lamboray JL
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):429-42. PubMed ID: 10437936
[TBL] [Abstract][Full Text] [Related]
6. Success in implementing Public Health Service guidelines to reduce perinatal transmission of HIV--Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Aug; 47(33):688-91. PubMed ID: 9733415
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
8. Mother-to-child HIV transmission in a cohort of pregnant women diagnosed by rapid HIV testing at Tijuana General Hospital, Baja California, Mexico.
Viani RM; Ruiz-Calderon J; Lopez G; Chacón-Cruz E; Spector SA
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):82-6. PubMed ID: 20335496
[TBL] [Abstract][Full Text] [Related]
9. The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
Palmer AL; Gay H; Currier MM
J Miss State Med Assoc; 2000 Feb; 41(2):479-83. PubMed ID: 10710894
[TBL] [Abstract][Full Text] [Related]
10. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
Wade NA; Birkhead GS; Warren BL; Charbonneau TT; French PT; Wang L; Baum JB; Tesoriero JM; Savicki R
N Engl J Med; 1998 Nov; 339(20):1409-14. PubMed ID: 9811915
[TBL] [Abstract][Full Text] [Related]
11. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
[TBL] [Abstract][Full Text] [Related]
12. Preventing perinatal HIV transmission: zidovudine use during pregnancy.
Carmichael C
Am Fam Physician; 1997 Jan; 55(1):171-4, 177-8. PubMed ID: 9012276
[TBL] [Abstract][Full Text] [Related]
13. Zidovudine use during pregnancy among HIV-infected women on Medicaid.
Sambamoorthi U; Akincigil A; McSpiritt E; Crystal S
J Acquir Immune Defic Syndr; 2002 Aug; 30(4):429-39. PubMed ID: 12138350
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
[TBL] [Abstract][Full Text] [Related]
15. Mothers on the margins: implications for eradicating perinatal HIV.
Lindau ST; Jerome J; Miller K; Monk E; Garcia P; Cohen M
Soc Sci Med; 2006 Jan; 62(1):59-69. PubMed ID: 15992982
[TBL] [Abstract][Full Text] [Related]
16. Successful implementation of perinatal HIV prevention guidelines. A multistate surveillance evaluation.
Wortley PM; Lindegren ML; Fleming PL
MMWR Recomm Rep; 2001 May; 50(RR-6):17-28. PubMed ID: 15580801
[TBL] [Abstract][Full Text] [Related]
17. Prenatal care and HIV infection.
Lancioni C; Harwell T; Rutstein RM
AIDS Patient Care STDS; 1999 Feb; 13(2):97-102. PubMed ID: 11362126
[TBL] [Abstract][Full Text] [Related]
18. Effects of ZDV-based patient education on intentions toward ZDV use, HIV testing and reproduction among a US cohort of women.
Healton C; Taylor S; Messeri P; Weinberg G; Bamji M
AIDS Care; 1999 Dec; 11(6):675-86. PubMed ID: 10716008
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
[TBL] [Abstract][Full Text] [Related]
20. Preventing perinatal human immunodeficiency virus transmission: factors influencing women's intentions toward zidovudine therapy.
Sowell RL; Murdaugh CL; Addy C; Moneyham L; Tavokoli A; Misener T
South Med J; 2001 Dec; 94(12):1177-84. PubMed ID: 11811856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
